Illumina, Inc. - Common Stock (ILMN)
235.99
-54.07 (-18.64%)
NASDAQ · Last Trade: Oct 30th, 11:45 PM EDT
News & Press Releases
Why Illumina (ILMN) shares are getting obliterated today
What happened? Shares of genomics company Illumina (NASDAQ:ILMN) fell 17.7% in the afternoon session after the company reported third-quarter 2026 financial ...
Via StockStory · October 30, 2026
Illumina (ILMN) Q3 2026 Earnings Call Transcriptfool.com
Clinical sequencing demand drives margin expansion and full-year guidance hikes.
Via The Motley Fool · October 30, 2026
S&P 500 Premarket Gainers and Losers on Oct. 30, 2026chartmill.com
Via Chartmill · October 30, 2026
Illumina Crashes As Tariffs, AI Woes Eat Into 157% Run-Upinvestors.com
Illumina stock crashed Friday, despite beating third-quarter expectations, on tariff confusion and a shaky backdrop for AI.
Via Investor's Business Daily · October 30, 2026
Illumina (NASDAQ:ILMN) Q3 Revenue Miss Overshadows EPS Beatchartmill.com
Via Chartmill · October 29, 2026
Illumina Q3 Earnings Call Highlightsmarketbeat.com
Illumina (NASDAQ:ILMN) reported third-quarter results above its prior guidance, citing strong clinical sequencing demand, elevated NovaSeq X instrument placements and disciplined spending. The company raised its full-year revenue, operating-margin and earnings outlook, while executives said they rem
Via MarketBeat · October 29, 2026
After-Hours S&P 500 Movers: Mondelez and FedEx Freight Gain, Intel and Reddit Fallchartmill.com
Via Chartmill · October 29, 2026
Illumina (NASDAQ:ILMN) reports sales below analyst estimates in Q3 2026 earnings, stock drops 16%
Genomics company Illumina (NASDAQ:ILMN) missed Wall Street’s revenue expectations in Q3 2026 as revenue rose 4.2% year on year to $1.13 billion. On the other...
Via StockStory · October 29, 2026
What to expect from Illumina’s (ILMN) Q3 earnings
Genomics company Illumina (NASDAQ:ILMN) will be reporting earnings this Thursday afternoon. Here’s what you need to know. Illumina beat analysts’ revenue exp...
Via StockStory · October 27, 2026
Which Biotech ETF Is the Better Buy: VanEck’s BBH or Invesco’s Factor-Driven PBE?fool.com
BBH offers lower costs and concentrated large-cap exposure, while PBE delivers higher dividend income and slightly better five-year returns through a multifactor strategy.
Via The Motley Fool · October 27, 2026
Which Healthcare ETF Is the Better Buy: Invesco’s Broad RSPH or First Trust’s Biotech FBT?fool.com
FBT has outperformed RSPH by a wide margin recently. The question is whether you want to own the fund that won last year or the one built to hold up over many years.
Via The Motley Fool · October 26, 2026
Invesco’s RSPH or iShares’ IBB: Which Healthcare ETF Is the Better Long-Term Buy?fool.com
RSPH offers broader healthcare exposure with lower volatility and higher dividend yield, while IBB provides concentrated biotech focus with stronger recent returns.
Via The Motley Fool · October 26, 2026
VanEck Biotech vs. Invesco Healthcare: Which ETF Offers More Potential for Long-Term Growth?fool.com
These two healthcare ETFs offer investors exposure to some of medicine's biggest names, but their different approaches to investing could lead to very different results.
Via The Motley Fool · October 25, 2026
S&P 500 Top Movers: Oct. 21, 2026 US Sessionchartmill.com
Via Chartmill · October 21, 2026
S&P 500 Top Movers on Oct. 21, 2026: Supermicro Leads Gainers, Dexcom Leads Loserschartmill.com
Via Chartmill · October 21, 2026
The AI Trade Just Moved Into Your Bloodstream, and 4 Healthcare Stocks Are Winningmarketbeat.com
AI-driven "biointelligence" is reshaping healthcare investing, with Guardant Health, Illumina, Eli Lilly and Moderna emerging as key stocks as data-driven testing, sequencing and therapies compound.
Via MarketBeat · October 19, 2026
3 Profitable Stocks We Steer Clear Of
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...
Via StockStory · October 12, 2026
Better Invesco Healthcare ETF: PJP Targeting Pharmaceuticals vs. RSPH's Broader Sector Lensfool.com
PJP's one-year return beats RSPH's, but RSPH offers broader diversification across 61 healthcare holdings at a lower expense ratio.
Via The Motley Fool · October 11, 2026
Better Biotechnology ETF: First Trust FBT vs. VanEck BBHfool.com
VanEck's lower 0.35% expense ratio appeals to cost-conscious investors, while First Trust's $2.9 billion in assets and equal-weighted approach offer broader diversification across 30 biotech holdings.
Via The Motley Fool · October 10, 2026
Which S&P500 stocks are gapping on Thursday?chartmill.com
Via Chartmill · October 8, 2026
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Via Chartmill · October 6, 2026
Which S&P500 stocks are moving on Tuesday?chartmill.com
Via Chartmill · October 6, 2026
Tuesday's session: gap up and gap down stock in the S&P500 indexchartmill.com
Via Chartmill · October 6, 2026
Stocks making big moves yesterday: Harley-Davidson, Illumina, TechnipFMC, Upstart, and DraftKings
Check out the companies making headlines yesterday: Harley-Davidson (NYSE:HOG): American motorcycle manufacturing company Harley-Davidson (NYSE:HOG) rose by ...
Via StockStory · October 6, 2026
Why PacBio (PACB) Stock Is Trading Up Today
What Happened? Shares of genomics company Pacific Biosciences of California (NASDAQ:PACB) jumped 9.9% in the afternoon session after EpiSign Inc. and Geneyx ...
Via StockStory · October 5, 2026